71 related articles for article (PubMed ID: 3408251)
1. [Prognostic factors in lung cancer].
Naruke T; Kondo H; Goya T; Tsuchiya R; Suemasu K
Gan To Kagaku Ryoho; 1988 Aug; 15(8):2179-85. PubMed ID: 3408251
[TBL] [Abstract][Full Text] [Related]
2. [Pathological variability and cancer treatment in lung cancer].
Kodama T
Gan To Kagaku Ryoho; 1986 Sep; 13(9):2708-17. PubMed ID: 3019250
[TBL] [Abstract][Full Text] [Related]
3. Lung cancer with chest wall involvement: predictive factors of long-term survival after surgical resection.
Voltolini L; Rapicetta C; Luzzi L; Ghiribelli C; Ligabue T; Paladini P; Gotti G
Lung Cancer; 2006 Jun; 52(3):359-64. PubMed ID: 16644062
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of subcarinal station in non-small cell lung cancer with T1-3 N2 disease.
Iwasaki A; Shirakusa T; Miyoshi T; Hamada T; Enatsu S; Maekawa S; Hiratsuka M
Thorac Cardiovasc Surg; 2006 Feb; 54(1):42-6. PubMed ID: 16485188
[TBL] [Abstract][Full Text] [Related]
5. [Prognostic factors in lung cancer based on Shanghai population].
Liao ML; Gao YT; Yang ZP
Zhonghua Jie He He Hu Xi Za Zhi; 1993 Feb; 16(1):36-8, 63-4. PubMed ID: 8403060
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of histology in resected lung cancer with emphasis on the relevance of the adenocarcinoma subtyping.
Riquet M; Foucault C; Berna P; Assouad J; Dujon A; Danel C
Ann Thorac Surg; 2006 Jun; 81(6):1988-95. PubMed ID: 16731118
[TBL] [Abstract][Full Text] [Related]
7. Surgical-pathologic factors affect long-term outcomes in stage IB (pT2 N0 M0) non-small cell lung cancer: a heterogeneous disease.
Hsu CP; Hsia JY; Chang GC; Chuang CY; Shai SE; Yang SS; Lee MC; Kwan PC
J Thorac Cardiovasc Surg; 2009 Aug; 138(2):426-33. PubMed ID: 19619791
[TBL] [Abstract][Full Text] [Related]
8. [Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].
Pfannschmidt J; Muley T; Hoffmann H; Bülzebruck H; Dienemann H
Dtsch Med Wochenschr; 2006 Nov; 131(47):2643-8. PubMed ID: 17109272
[TBL] [Abstract][Full Text] [Related]
9. Surgical treatment of primary lung cancer with synchronous brain metastases.
Billing PS; Miller DL; Allen MS; Deschamps C; Trastek VF; Pairolero PC
J Thorac Cardiovasc Surg; 2001 Sep; 122(3):548-53. PubMed ID: 11547308
[TBL] [Abstract][Full Text] [Related]
10. [Surgery and adjuvant therapy of non-small cell lung cancer].
Watanabe Y; Yamada T; Ichihashi T; Hashizume Y; Iwa T
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1534-46. PubMed ID: 3524465
[TBL] [Abstract][Full Text] [Related]
11. [Clinicopathologic features of lung pleomorphic (spindle/giant cell) carcinoma--a report of 17 cases].
Zhao ZL; Song N; Huang QY; Liu YP; Zhao HR
Ai Zheng; 2007 Feb; 26(2):183-8. PubMed ID: 17298750
[TBL] [Abstract][Full Text] [Related]
12. Results of superior vena cava resection for lung cancer. Analysis of prognostic factors.
Spaggiari L; Magdeleinat P; Kondo H; Thomas P; Leon ME; Rollet G; Regnard JF; Tsuchiya R; Pastorino U
Lung Cancer; 2004 Jun; 44(3):339-46. PubMed ID: 15140547
[TBL] [Abstract][Full Text] [Related]
13. [Surgical treatment for clinical stage II and III small cell lung cancer patients].
Kawano R; Tamaki K; Karita S; Yokota T; Ikeda S; Hata E
Kyobu Geka; 2006 Sep; 59(10):879-83; discussion 883-6. PubMed ID: 16986681
[TBL] [Abstract][Full Text] [Related]
14. Subcategorization of resectable non-small cell lung cancer involving neighboring structures.
Sakakura N; Mori S; Ishiguro F; Fukui T; Hatooka S; Shinoda M; Yokoi K; Mitsudomi T
Ann Thorac Surg; 2008 Oct; 86(4):1076-83; discussion 1083. PubMed ID: 18805135
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value and therapeutic consequences of vascular invasion in non-small cell lung carcinoma.
Bodendorf MO; Haas V; Laberke HG; Blumenstock G; Wex P; Graeter T
Lung Cancer; 2009 Apr; 64(1):71-8. PubMed ID: 18790545
[TBL] [Abstract][Full Text] [Related]
16. [Multivariate survival analysis of 899 patients with non-small cell lung cancer after complete resection].
Wei WD; Wen ZS; Su XD; Lin P; Rong TH; Chen LK
Ai Zheng; 2007 Nov; 26(11):1231-6. PubMed ID: 17991324
[TBL] [Abstract][Full Text] [Related]
17. Association of immunoreactive hepatocyte growth factor with poor survival in resectable non-small cell lung cancer.
Siegfried JM; Weissfeld LA; Singh-Kaw P; Weyant RJ; Testa JR; Landreneau RJ
Cancer Res; 1997 Feb; 57(3):433-9. PubMed ID: 9012470
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer.
Matsuoka K; Sumitomo S; Nakashima N; Nakajima D; Misaki N
Eur J Cardiothorac Surg; 2007 Sep; 32(3):435-9. PubMed ID: 17611117
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors in resected satellite-nodule T4 non-small cell lung cancer.
Rao J; Sayeed RA; Tomaszek S; Fischer S; Keshavjee S; Darling GE
Ann Thorac Surg; 2007 Sep; 84(3):934-8; discussion 939. PubMed ID: 17720402
[TBL] [Abstract][Full Text] [Related]
20. [Lung cancer in Senegal].
Niang A; Bonnichon A; Ba-Fall K; Dussart C; Camara P; Vaylet F; Mbaye PS; L'Her P; Sane M; Margery J
Med Trop (Mars); 2007 Dec; 67(6):651-6. PubMed ID: 18300532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
